Evidence map›Paper›PMID 26476196›Full record

ArticleBiomaterials2016

Proteomic analysis of naturally-sourced biological scaffolds.

Qiyao Li, Basak E Uygun, Sharon Geerts, Sinan Ozer, Mark Scalf, Sarah E Gilpin, Harald C Ott, Martin L Yarmush, Lloyd M Smith, Nathan V Welham and 1 more

Abstract read
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Article
  3. Ex vivo assay for organ-specific cancer cell invasion.Journal of biological engineering · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. In vitro liver models for toxicological research.Drug metabolism and pharmacokinetics · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Clinical Translation of Engineered Pulmonary Vascular Models.Advances in experimental medicine and biology · 2023
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qiyao LiDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Basak E UygunCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02114, USA.
Sharon GeertsCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02114, USA.
Sinan OzerCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02114, USA.
Mark ScalfDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Sarah E GilpinCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Harald C OttCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Martin L YarmushCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02114, USA.
Lloyd M SmithDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Nathan V WelhamDivision of Otolaryngology, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA. Electronic address: welham@surgery.wisc.edu.
Brian L FreyDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: bfrey@chem.wisc.edu.

Funding

PHONOSURGICAL OPTIMIZATION CRITERIA FOR SULCUS VOCALISR01DC004428 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI Nathan Welham · 2000 to 2026
$8.7M
Regeneration of Multi-Layered Vocal Fold MucosaR01DC010777 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI WELHAM, NATHAN · 2010 to 2020
$5.3M
Recellularization of Liver BioscaffoldsR01DK084053 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, BASAK ELIF, YARMUSH, MARTIN L · 2009 to 2020
$4.6M
Use of Discarded Organs for Preparation of Liver GraftsR00DK088962 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, BASAK ELIF · 2014 to 2016
$844k
NIDCD NIH HHS R01 DC004428NIDCD NIH HHS R01 DC010777NIDCD NIH HHS R01 DC010777-S1NIDDK NIH HHS R00 DK088962NIDDK NIH HHS R01 DK084053
6 · The paper itself

Abstract

A key challenge to the clinical implementation of decellularized scaffold-based tissue engineering lies in understanding the process of removing cells and immunogenic material from a donor tissue/organ while maintaining the biochemical and biophysical properties of the scaffold that will promote growth of newly seeded cells. Current criteria for evaluating whole organ decellularization are primarily based on nucleic acids, as they are easy to quantify and have been directly correlated to adverse host responses. However, numerous proteins cause immunogenic responses and thus should be measured directly to further understand and quantify the efficacy of decellularization. In addition, there has been increasing appreciation for the role of the various protein components of the extracellular matrix (ECM) in directing cell growth and regulating organ function. We performed in-depth proteomic analysis on four types of biological scaffolds and identified a large number of both remnant cellular and ECM proteins. Measurements of individual protein abundances during the decellularization process revealed significant removal of numerous cellular proteins, but preservation of most structural matrix proteins. The observation that decellularized scaffolds still contain many cellular proteins, although at decreased abundance, indicates that elimination of DNA does not assure adequate removal of all cellular material. Thus, proteomic analysis provides crucial characterization of the decellularization process to create biological scaffolds for future tissue/organ replacement therapies.

Indexed as

AnimalsBlotting, WesternCollagenCollagen Type IDNADrug CombinationsFemaleHumansIntercellular Signaling Peptides and ProteinsLamininLiverLungProteoglycansProteomicsRats, Inbred LewTissue ScaffoldsCollagenCollagen Type IDNADrug CombinationsIntercellular Signaling Peptides and ProteinsLamininmatrigelProteoglycansDecellularized human lungDecellularized rat liverMass spectrometryMatrigelMatrisomeProteomics

Identifiers

PMID26476196
PMCPMC4644483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.